Bolt Biotherapeutics (BOLT)
(Delayed Data from NSDQ)
$0.65 USD
+0.01 (0.78%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $0.65 +0.01 (0.78%) 7:44 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.36 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | -3.70% |
ABR | 3.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.52 |
Next Year | -0.99 |
EPS (TTM) | -1.74 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.02M | 0.93M | 8.47M | 4.86M |
# of Estimates | 3 | 3 | 3 | 3 |
High Estimate | 1.75M | 1.45M | 9.74M | 9.99M |
Low Estimate | 0.50M | 0.40M | 7.40M | 0.80M |
Year ago Sales | 2.53M | 2.09M | 7.88M | 8.47M |
Year over Year Growth Est. | -59.84% | -55.69% | 7.58% | -42.69% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.36 | -0.32 | -1.52 | -0.99 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.31 | -0.30 | -1.45 | -0.99 |
High Estimate | -0.24 | -0.26 | -1.34 | -0.91 |
Low Estimate | -0.46 | -0.36 | -1.66 | -1.07 |
Year ago EPS | -0.43 | -0.47 | -1.83 | -1.52 |
Year over Year Growth Est. | 16.28% | 31.91% | 16.94% | 34.65% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.36 | -0.32 | -1.52 | -0.99 |
7 Days Ago | -0.43 | -0.30 | -1.44 | -0.95 |
30 Days Ago | -0.43 | -0.30 | -1.44 | -0.95 |
60 Days Ago | -0.43 | -0.29 | -1.40 | -0.89 |
90 Days Ago | -0.43 | -0.29 | -1.40 | -0.89 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.32 | -1.52 | -0.99 |
Zacks Consensus Estimate | -0.36 | -0.32 | -1.52 | -0.99 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -0.28 | -0.47 | -0.43 | NA |
Estimate | -0.54 | -0.51 | -0.47 | -0.49 | NA |
Difference | -0.02 | 0.23 | 0.00 | 0.06 | 0.07 |
Surprise | -3.70% | 45.10% | 0.00% | 12.24% | 13.41% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more